Drugmakers including Pfizer, GlaxoSmithKline, Bristol Myers Squibb, AstraZeneca and Sanofi plan to raise prices in US on more than 350 unique drugs
More drug prices are likely to be announced over the course of January — historically the biggest month for drugmakers to raise prices.
The industry is also contending with inflation and supply chain constraints that have led to higher manufacturing costs. To date, Pfizer announced the most increases, with prices rising on 89 unique drug brands and an additional increase on 10 drug brands at its Hospira arm. A company spokesperson said there were several driving factors in increasing the list price of the two CAR-T cell therapies, including the rate of inflation, the value of the therapies, and the personalised nature of the CAR-T manufacturing process.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Big Pharma and GOP Allies Aim to Sabotage Medicare Drug Price Reforms'All the contributions they make and all their lobbying money gives them a lot of power,' Democratic Rep. Peter Welch said of the pharmaceutical industry.
Baca lebih lajut »
Big Pharma and GOP Allies Aim to Sabotage Medicare Drug Price ReformsThe pharmaceutical industry and its Republican allies in Congress are openly signaling their plans obstruct at every turn as the Biden administration looks to begin implementing a recently passed law that will allow Medicare to negotiate drug prices for the first time in its history.
Baca lebih lajut »
Big Pharma and GOP Open About Plans to Obstruct Medicare Drug Price ReformsWhile the reforms are less ambitious than what progressives wanted, they could still have a significant impact on costs.
Baca lebih lajut »
Justice Department sues pharma distributor AmerisourceBergen over opioid ordersOne of the nation's largest distributors of prescription drugs failed hundreds of thousands of times to report suspicious orders of opioids, fueling the country's opioids epidemic, U.S. prosecutors have announced.
Baca lebih lajut »
Feds accuse pharma giant of drug law violations that fed opioid epidemicThe Department of Justice highlighted the actions of pharmacies to illustrate their accusations against AmerisourceBergen.
Baca lebih lajut »
DOJ sues pharma giant AmerisourceBergen Corp. for allegedly helping to fuel the opioid epidemicThe Justice Department is suing AmerisourceBergen Corp., accusing the pharmaceutical giant of helping fuel the opioid epidemic by allegedly repeatedly failing to report suspicious orders of opioids for nearly a decade.
Baca lebih lajut »